Related Experiment Video
Updated: Sep 29, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Severe cardiomyopathy associated with the VCP p.R155C and c.177_187del MYBPC3 gene variants
Nicole Choy1, Stephani Wang2, Pablo Abbona3
1Division of Genetics and Genomic Medicine, Department of Pediatrics, University of California, Irvine, CA, USA; Department of Genetics, Kaiser Permanente, San Bernadino County, Fontana, CA, USA.
Insights
This study details a rare case of concurrent MYBPC3 and VCP gene variants, leading to early-onset, severe cardiomyopathy. These genetic findings offer new insights into the complex mechanisms of heart disease.
Area of Science:
- Genetics
- Cardiology
- Neurology
Background:
- Inclusion Body Myopathy, Paget's Disease of Bone, with Frontotemporal Dementia (IBMPFD) is a progressive, autosomal dominant disorder.
- IBMPFD is caused by variants in the Valosin Containing Protein (VCP) gene, affecting the ubiquitin-proteasome complex.
- Cardiomyopathy is a known, albeit typically late-stage, complication of VCP-associated IBMPFD.
Observation:
- A patient presented with acute onset of dilated cardiomyopathy.
- Genetic testing revealed concurrent pathogenic variants in both the MYBPC3 and VCP genes.
- The identified variants were MYBPC3 c.177_187del and VCP p.R155C.
Findings:
- This is the first reported case of concurrent MYBPC3 and VCP pathogenic variants.
- The combined variants led to an earlier onset and a more severe presentation of cardiomyopathy than typically observed with VCP variants alone.
- The findings suggest a potential synergistic effect of these genetic variants on cardiac function.
Implications:
- This case expands the understanding of genotype-phenotype correlations in IBMPFD and related cardiomyopathies.
- It highlights the importance of comprehensive genetic testing in patients with unexplained or rapidly progressing cardiomyopathy.
- Further research into the interaction between MYBPC3 and VCP variants may reveal novel therapeutic targets for genetic cardiomyopathies.
Abstract:
Inclusion Body Myopathy, Paget's Disease of Bone, with Frontotemporal Dementia is a progressive autosomal dominant disease that affects the ubiquitin-proteasome complex, that is caused by variants in the Valosin Containing Protein (VCP) gene. We report the first case of concurrent pathogenic variants in both MYBPC3 and VCP that led to earlier onset of congestive heart failure with features of dilated cardiomyopathy. Cardiomyopathy has previously been associated with VCP inclusion body myopathy mostly at an advanced stage of the disease. Due to acute onset of cardiomyopathy in a previous asymptomatic individual, a cardiomyopathy gene panel was obtained which revealed an additional c.177_187del variant of the MYBPC3 gene. We report a first case of concurrent pathogenic variants in both c.177_187del gene of MYBPC3 and p.R155C VCP that led to earlier onset and a more severe form of the cardiomyopathy.
More Related Videos
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Mitral Valve Prolapse I: Introduction